In the absence of contemporary, population-based epidemiological studies, estimates of the
incidence and prevalence of the inherited cardiomyopathies have been derived from …

In this scientific statement from the American Heart Association, experts in the field of
cardiomyopathy (heart muscle disease) in children address 2 issues: the most current …

Dilated cardiomyopathy (DCM) is a clinical diagnosis characterized by left ventricular or
biventricular dilation and impaired contraction that is not explained by abnormal loading …

Background Previous studies have demonstrated that children in the United States who
were of racial and ethnic minorities have inferior waitlist and post-heart transplant (HT) …

Background Pediatric cardiomyopathy is a genetically heterogeneous disease with
substantial morbidity and mortality. Current guidelines recommend genetic testing in …

Background Pediatric dilated cardiomyopathy (DCM) is a well‐known clinical entity;
however, phenotype–genotype correlations are inadequately described. Our objective was …

Racially disparate health outcomes exist for a multitude of populations and illnesses. It is
unknown how race and ethnicity impact mortality for children with cardiomyopathy or …

The incidence of new-onset atrial fibrillation (NOAF) is increasing both in the Asian
populations and Western countries. Several demographic and clinical risk factors were …

Pediatric heart failure (PHF) data has wide variation due to the scarcity of large multicenter
studies. Literature is based mostly on single-center publications. A systematic review by …

The prevalence of Heart failure (HF) is increasing with the aging of the population but it is
estimated that 10% of HF patients are younger than 50 years-old. HF development in this …